Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Unaudited Quarterly Financial results (Standalone and Consolidation Basis) of the Company for the period ended 30th June 2024